 REHOVOT, Israel, May 11, 2022 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ TASE: KMDA, a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, today announced that it will release financial results for the first quarter ended March 31, 2022, prior to the open of the U.S. financial markets on Tuesday, May 17, 2022. 